Mycobiology

The Korean Society of Mycology (한국균학회)
권호 표지
DOI QR코드

DOI QR Code

Identification and Antifungal Susceptibility Profiles of Cyberlindnera fabianii in Korea

  • Park, Ji-Hyun (Translational Research Division, Biomedical Institute of Mycological Resource, International St. Mary's Hospital and College of Medicine, Catholic Kwandong University) ;
  • Oh, Junsang (Translational Research Division, Biomedical Institute of Mycological Resource, International St. Mary's Hospital and College of Medicine, Catholic Kwandong University) ;
  • Sang, Hyunkyu (Translational Research Division, Biomedical Institute of Mycological Resource, International St. Mary's Hospital and College of Medicine, Catholic Kwandong University) ;
  • Shrestha, Bhushan (Translational Research Division, Biomedical Institute of Mycological Resource, International St. Mary's Hospital and College of Medicine, Catholic Kwandong University) ;
  • Lee, Hyeyoung (Department of Laboratory Medicine, International St. Mary's Hospital and College of Medicine, Catholic Kwandong University) ;
  • Koo, Jehyun (Department of Laboratory Medicine, International St. Mary's Hospital and College of Medicine, Catholic Kwandong University) ;
  • Cho, Sung-Il (Department of Laboratory Medicine, International St. Mary's Hospital and College of Medicine, Catholic Kwandong University) ;
  • Choi, Ji Seon (Department of Laboratory Medicine, International St. Mary's Hospital and College of Medicine, Catholic Kwandong University) ;
  • Lee, Min-Ha (Department of Laboratory Medicine, International St. Mary's Hospital and College of Medicine, Catholic Kwandong University) ;
  • Kim, Jayoung (Department of Laboratory Medicine, International St. Mary's Hospital and College of Medicine, Catholic Kwandong University) ;
  • Sung, Gi-Ho (Translational Research Division, Biomedical Institute of Mycological Resource, International St. Mary's Hospital and College of Medicine, Catholic Kwandong University)
  • Received : 2019.05.17
  • Accepted : 2019.07.31
  • Published : 2019.12.01
Download PDF
⟨ Previous Next ⟩

Abstract

Invasive fungal infections caused by Cyberlindnera fabianii have recently increased. However, biochemical kits such as API 20 C AUX and Vitek-2C have misidentified this species as other Candida spp. such as C. pelliculosa or C. utilis due to no information of Cy. fabianii in yeast database. During our 2016-2017 surveys, eleven isolates of Cy. fabianii were obtained in International St. Mary's Hospital in Korea. Here, we describe its morphological and molecular characteristics and tested its antifungal susceptibility against nine antifungal agents. The sequences of the ITS region and the D1/D2 region of LSU revealed 100% identity with the sequences of Cy. fabianii. In comparison with the results from MALDI-TOF mass spectrometry, we found that Cy. fabianii can be distinguished from other species. In antifungal susceptibility test, voriconazole and echinocandins exhibited good antifungal activities against the majority of Cy. fabianii isolates despite the absence of standard criteria.

Keywords

References

  1. Svobodova L, Bednarova D, Ruzicka F, et al. High frequency of Candida fabianii among clinical isolates biochemically identified as Candida pelliculosa and Candida utilis. Mycoses. 2016;59:241-246. https://doi.org/10.1111/myc.12454
  2. Grenouillet F, Millon L, Chamouine A, et al. Pichia fabianii fungemia in a neonate. Pediatr Infect Dis J. 2010;29:191. https://doi.org/10.1097/INF.0b013e3181c4f7d9
  3. Wu Y, Wang J, Li W, et al. Pichia fabianii blood infection in a premature infant in China: case report. BMC Res Notes. 2013;6:77. https://doi.org/10.1186/1756-0500-6-77
  4. Yun JW, Park KS, Ki CS, et al. Catheter-related bloodstream infection by Lindnera fabianii in a neutropenic patient. J Med Microbiol. 2013;62:922-925. https://doi.org/10.1099/jmm.0.048306-0
  5. Mlinaric-Missoni E, Hatvani L, Kocsube S, et al. Cyberlindnera fabianii in the neonatal and paediatric intensive care unit: case reports. JMM Case Rep. 2015;2:1-6. https://doi.org/10.1099/jmmcr.0.000032.
  6. Lee JI, Yu S, Park JS, et al. Successful treatment of fungemia caused by Cyberlindnera fabianii with Anidulafungin: a case report. Ann Clin Microbiol. 2015;18:94-97. https://doi.org/10.5145/ACM.2015.18.3.94
  7. Kim YJ, Yang JJ, Lee HJ. Possibility of frequent detection of invasive Cyberlindnera fabianii infection using molecular method. Ann Clin Microbiol. 2015;18:133-134. https://doi.org/10.5145/ACM.2015.18.4.133
  8. White TJ, Bruns T, Lee S, et al. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics In: Innis MA, Gelfand DH, Sninsky JJ, White TJ, editors. PCR protocols: a guide to methods and applications. San Diego, CA, USA: Academic Press; 1990. p. 315-322.
  9. O'Donnell K. Fusarium and its near relatives In: Reynolds DR, Taylor JW, editors. The fungal holomorph: mitotic, meiotic and pleomorphic speciation in fungal systematics. Wallingford, United Kingdom: CAB International; 1993. p. 529-580.
  10. Tamura K, Stecher G, Peterson D, et al. MEGA6: molecular evolutionary genetics analysis version 6.0. Mol Biol Evol. 2013;30:2725-2729. https://doi.org/10.1093/molbev/mst197
  11. Clinical and Laboratory Standards Institute (CLSI). M27-S4 Reference method for broth dilution antifungal susceptibility testing of yeasts: fourth informational supplement M27-S4. Wayne, PA: Clinical and Laboratory Standards Institute; 2012.
  12. Minter DW. Cyberlindnera, a replacement name for Lindnera kurtzman et al., nom. illegit. Mycotaxon. 2009;110:473-476. https://doi.org/10.5248/110.473
  13. Hamal P, Ostransky J, Dendis M, et al. A case of endocarditis caused by the yeast Pichia fabianii with biofilm production and developed in vitro resistance to azoles in the course of antifungal treatment. Med Mycol. 2008;46:601-605. https://doi.org/10.1080/13693780802078180
  14. Baghdadi J, Hemarajata P, Humphries R, et al. First report of ventriculoperitoneal shunt infection due to Cyberlindnera fabianii. Case Rep Infect Dis. 2015;630816:1-6.
  15. Jindal N, Arora S, Dhuria N, et al. Cyberlindnera (Pichia) fabianii infection in a neutropenic child: importance of molecular identification. JMM Case Rep. 2015;2:1-3. http://dx.doi.org/10.1099/jmmcr.0.000033.
  16. Hof H, Amann V, Tauber C, et al. Peritonitis in a neonate due to Cyberlindnera fabianii, an ascomycetic yeast. Infection. 2017;45:921-924. https://doi.org/10.1007/s15010-017-1062-8
  17. Bhally HS, Jain S, Shields C, et al. Infection in a neonate caused by Pichia fabianii: importance of molecular identification. Med Mycol. 2006;44:185-187. https://doi.org/10.1080/13693780500160793
  18. Gabriel F, Noel T, Accoceberry I. Lindnera (Pichia) fabianii blood infection after mesenteric ischemia. Med Mycol. 2012;50:310-314. https://doi.org/10.3109/13693786.2011.587455
  19. Valenza G, Valenza R, Brederlau J, et al. Identification of Candida fabianii as a causal of lethal septicaemia. Mycoses. 2006;49:331-334. https://doi.org/10.1111/j.1439-0507.2006.01240.x
  20. Zhao Y, Tsang CC, Xiao M, et al. Yeast identification by sequencing, biochemical kits, MALDI-TOF MS and rep-PCR DNA fingerprinting. Med Mycol. 2018;56:816-827. https://doi.org/10.1093/mmy/myx118
  21. Haas M, Grenouillet F, Loubersac S, et al. Identification of cryptic Candida species by MALDI-TOF mass spectrometry, not all MALDITOF systems are the same: focus on the C. parapsilosis species complex. Diagn Microbial Infect Dis. 2016;84:385-386.
  22. Ghosh AK, Paul S, Sood P, et al. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry for the rapid identification of yeasts causing bloodstream infections. Clin Microbiol Infect. 2015;21:372-378. https://doi.org/10.1016/j.cmi.2014.11.009
  23. Richard MJ, Edwards JR, Culver DH, et al. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med. 1999;27:887-892. https://doi.org/10.1097/00003246-199905000-00020
  24. Nicolle LE. Catheter associated urinary tract infections. Antimicrob Resist Infect Control. 2014;3:23. https://doi.org/10.1186/2047-2994-3-23
  25. Kaur R, Dhakad MS, Goyal R, et al. Emergence of non-albicans Candida species and antifungal resistance in intensive care unit patients. Asian Pac J Trop Biomed. 2016;6:455-460. https://doi.org/10.1016/j.apjtb.2015.12.019
  26. Bukhary ZA. Candiduria: a review of clinical significance and management. Saudi J Kidney Dis Transpl. 2008;19:350-360.
  27. Kauffman CA. Candiduria. Clin Infect Dis. 2005;41:S371-S376. https://doi.org/10.1086/430918

Cited by

  1. Rare Invasive Yeast Infections in Greek Neonates and Children, a Retrospective 12-Year Study vol.6, pp.4, 2019, https://doi.org/10.3390/jof6040194
  2. Azole Susceptibility Profiles of More than 9,000 Clinical Yeast Isolates Belonging to 40 Common and Rare Species vol.65, pp.6, 2019, https://doi.org/10.1128/aac.02615-20
  3. Fungaemia due to rare yeasts in paediatric intensive care units: A prospective study vol.64, pp.11, 2019, https://doi.org/10.1111/myc.13297